The Institute of Microbiology under the Chinese Academy of Sciences has developed an antiviral medicine for COVID-19, called JS016. The medication is now under phase-III clinical trials and has been used for emergency treatment both domestically and overseas.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3